These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9288947)

  • 1. Identification of an ubiquitin-ligation system for the epidermal-growth-factor receptor--herbimycin A induces in vitro ubiquitination in rabbit-reticulocyte lysate.
    Mori S; Tanaka K; Kanaki H; Nakao M; Anan T; Yokote K; Tamura K; Saito Y
    Eur J Biochem; 1997 Aug; 247(3):1190-6. PubMed ID: 9288947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
    Murakami Y; Fukazawa H; Mizuno S; Uehara Y
    Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.
    Murakami Y; Fukazawa H; Mizuno S; Uehara Y
    Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):57-62. PubMed ID: 8037691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.
    Sepp-Lorenzino L; Ma Z; Lebwohl DE; Vinitsky A; Rosen N
    J Biol Chem; 1995 Jul; 270(28):16580-7. PubMed ID: 7622464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells.
    Murakami Y; Mizuno S; Uehara Y
    Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):63-8. PubMed ID: 8037692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the protein tyrosine kinase inhibitor, herbimycin A, on prolactin gene expression in GH3 and 235-1 pituitary tumor cells.
    Billis WM; White BA
    Biochim Biophys Acta; 1997 Aug; 1358(1):31-8. PubMed ID: 9296518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line.
    Shiozaki H; Kadowaki T; Doki Y; Inoue M; Tamura S; Oka H; Iwazawa T; Matsui S; Shimaya K; Takeichi M
    Br J Cancer; 1995 Feb; 71(2):250-8. PubMed ID: 7530982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cells.
    Makishima M; Yamamoto-Yamaguchi Y; Honma Y
    Biochim Biophys Acta; 1995 Dec; 1272(3):199-205. PubMed ID: 8541353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.
    Graber M; June CH; Samelson LE; Weiss A
    Int Immunol; 1992 Nov; 4(11):1201-10. PubMed ID: 1472473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.
    Magnifico A; Tagliabue E; Ardini E; Casalini P; Colnaghi MI; Ménard S
    FEBS Lett; 1998 Jan; 422(2):129-31. PubMed ID: 9489990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular retention and degradation of the epidermal growth factor receptor, two distinct processes mediated by benzoquinone ansamycins.
    Supino-Rosin L; Yoshimura A; Yarden Y; Elazar Z; Neumann D
    J Biol Chem; 2000 Jul; 275(29):21850-5. PubMed ID: 10806200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases.
    Sakagami M; Morrison P; Welch WJ
    Cell Stress Chaperones; 1999 Mar; 4(1):19-28. PubMed ID: 10467105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor regulates Ca2+ uptake in primary cultured renal proximal tubule cells: involvement of cAMP, PKC and cPLA2.
    Han HJ; Park SH; Lee YJ
    Kidney Blood Press Res; 2003; 26(3):155-64. PubMed ID: 12886043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ret tyrosine kinase activity by herbimycin A.
    Taniguchi M; Uehara Y; Matsuyama M; Takahashi M
    Biochem Biophys Res Commun; 1993 Aug; 195(1):208-14. PubMed ID: 8363602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.
    Yoneda T; Lowe C; Lee CH; Gutierrez G; Niewolna M; Williams PJ; Izbicka E; Uehara Y; Mundy GR
    J Clin Invest; 1993 Jun; 91(6):2791-5. PubMed ID: 8514886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbimycin B, a new benzoquinonoid ansamycin with anti-TMV and herbicidal activities.
    Iwai Y; Nakagawa A; Sadakane N; Omura S; Oiwa H; Matsumoto S; Takahashi M; Ikai T; Ochiai Y
    J Antibiot (Tokyo); 1980 Oct; 33(10):1114-9. PubMed ID: 7451361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
    Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
    Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in cAMP phosphodiesterase activity in hepatocytes cultured with herbimycin A due to cellular microtubule polymerization related to inhibition of tyrosine phosphorylation of alpha-tubulin.
    Ishibashi K; Fujioka T; Ui M
    Eur J Biochem; 1999 Mar; 260(2):398-408. PubMed ID: 10095774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression?
    Morris SD; Cumming DV; Latchman DS; Yellon DM
    J Clin Invest; 1996 Feb; 97(3):706-12. PubMed ID: 8609226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
    Blair HC; Jordan SE; Peterson TG; Barnes S
    J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.